Showing results (861-870 of 1,522) with videos related to
Sort By:
Pageof 153
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 22, 2013
Endoscopic ultrasonography--a sensitive tool in the preoperative localization of insulinomaA J Joseph, Nitin Kapoor, Ebby G Simon, et al.Journal of the American College of Cardiology|December 20, 2005
Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study programAngel R León, William T Abraham, Anne B Curtis, et al.Circulation|October 28, 2009
Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failureMartin St John Sutton, Stefano Ghio, Ted Plappert, et al.The Journal of Thoracic and Cardiovascular Surgery|January 9, 2008
Worldwide surgical experience with the Paracor HeartNet cardiac restraint deviceCharles T Klodell, Juan M Aranda, David C McGiffin, et al.Cardiovascular Drugs and Therapy|May 1, 1997
Second- and third-generation beta-blocking drugs in chronic heart failureM R Bristow, W T Abraham, T Yoshikawa, et al.Journal of Analytical Toxicology|October 31, 2009
Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humansTsadik T Abraham, Allan J Barnes, Ross H Lowe, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 28, 2017
The Utility of a Wireless Implantable Hemodynamic Monitoring System in Patients Requiring Mechanical Circulatory SupportDavid S Feldman, Nader Moazami, Philip B Adamson, et al.Circulation|October 15, 1995
Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damageM White, R J Wiechmann, R L Roden, et al.European Heart Journal|September 1, 2009
Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysisRutger J van Bommel, Jeroen J Bax, William T Abraham, et al.Circulation|March 20, 2002
BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapyStephen S Gottlieb, D Craig Brater, Ignatius Thomas, et al.Pageof 153